Melinta Therapeutics to Present at 34th Annual J.P. Morgan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Melinta Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference

New Haven, CT, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced that Dr. Eugene Sun, the Company’s interim Chief Executive Officer, will be providing a corporate update at the 34th annual J.P. Morgan Healthcare Conference in San Francisco, CA. Melinta’s presentation will take place on Tuesday, January 12, 2016 at 10:00am Pacific Time, and will include an update on Baxdela ( delafloxacin ), the Company’s lead candidate for hospital-treated skin infections and hospital-treated community-acquired bacterial pneumonia. The first of two Phase 3 studies of Baxdela (study 302) in hospital-treated skin infections met the study's primary objective endpoint; the second Phase 3 study of IV and oral Baxdela in this indication (study 303) has completed enrollment with data expected in the first half of 2016.

The J.P. Morgan Healthcare Conference is the largest healthcare investment symposium in the industry, bringing together global industry leaders, emerging companies, technology innovators and members of the investment community.  Attendance at this conference is by invitation only.

About Baxdela

Baxdela (delafloxacin) is an investigational anionic fluoroquinolone antibiotic currently in Phase 3 clinical development for hospital-treated skin infections, known as acute bacterial skin and skin structure infections (ABSSSI). The ABSSSI PROCEED studies (studies 302 (RX-3341-302 (NCT01811732)) and 303 (RX-3341-303 (NCT01984684))) are Phase 3, multicenter, multi-national, randomized, double-blind, active-controlled trials to evaluate Baxdela compared with vancomycin + aztreonam for the treatment of patients with ABSSSI. The PROCEED studies are evaluating Baxdela in both IV and oral formulations.  Baxdela has been designated a Qualified Infectious Disease Product (QIDP) for both ABSSSI and community-acquired bacterial pneumonia by the U.S. Food and Drug Administration.

About Melinta Therapeutics

Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global public health crisis of bacterial infections through the development of novel antibiotics that provide new and better therapeutic solutions. Melinta is rapidly progressing its late-stage investigational antibiotic, Baxdela, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). Melinta is committed to developing, through the application of Nobel Prize-winning science, a new class of antibiotics designed to overcome the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens ( Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and Escherichia coli ), which cause the majority of life-threatening hospital infections.

Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners ( www.vaterahealthcare.com ) and Malin Corporation plc ( www.malinplc.com ) among other private investors.  The company is headquartered in New Haven, CT with offices in Lincolnshire, IL. Visit www.melinta.com for more information.

Melinta Therapeutics Kathy Powell (312) 724-9400 news@melinta.com Media Contact Aline Sherwood (312) 238-8957 asherwood@scientapr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pyxus Starts Exchange Offer for 8.50% Notes, 2027

Updated Category News Views 70

Pyxus Restructures Via Exchange Offer Pites, it's time for Pyxus International to show its hand. The global agricultural player has rolled up its sleeves, kicking off an exchange offer for its 8.50% notes maturing in 2027. With $148.3 million hanging in the balance, this move is their shot at managing debt and keeping things steady—like a farmer making sure the...

Continue Reading
Nevada Organic Phosphate Cancels Share Consolidation Plan

Updated Category News Views 42

Unexpected Turn for Nevada Organic Phosphate In an abrupt twist that surprised some investors, Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) (FSE: ZV8), the Canadian trailblazer in organic phosphate mining, called off its proposed share consolidation. Dropping the plan wasn't just a stroke of luck; it came after hearing the grumblings of shareholders concerned...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 136

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 64

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
PMET's High-Stakes Call on Shaakichiuwaanaan Update

Updated Category News Views 25

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

Continue Reading
GFL Stays Public: Board Sees Growth Beyond Buyout

Updated Category News Views 69

GFL Environmental Says 'No Thanks' to Takeover Bids Wall Street loves a juicy M&A story, but GFL Environmental decided it’s not playing ball. In a world where companies seem to flip like properties on a hot market, GFL has boldly told prospective buyers to buzz off. They want to stay public, continue carving their path without the trappings of private equity overlords....

Continue Reading
HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

Updated Category News Views 156

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 136

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 81

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
Solar Cooking Revolution: InventHelp's Latest Innovation

Updated Category News Views 16

A Bright Idea Shines with Solar Cooking Some days, you stumble across an idea that just seems destined to shake things up, and COOK SOL SOLAR POWER COOKER might just be one of those spark plugs ready to ignite the world of outdoor cooking. Invented by a plucky thinker from Florence, South Carolina, this little gadget isn't just about frying up eggs on a camping trip. Nah,...

Continue Reading

Top 5 Most Recently Viewed Articles

GTIA Introduces Significant Charitable Giving Initiative

Updated Category News Views 253

GTIA's Charitable Commitment for 2025 During a notable event at ChannelCon, the Global Technology Industry Association (GTIA) revealed an ambitious plan to contribute $1.5 million to charitable causes in 2025. This pledge includes a noteworthy $50,000 grant awarded to a local nonprofit organization focused on supporting underprivileged youth. The announcement illustrates...

Continue Reading
Revolutionary TIL Therapy Shows Promise for Treating Tumors

Updated Category News Views 40

Advancements in Tumor-Infiltrating Lymphocyte Therapy Turnstone Biologics is at the forefront of developing a cutting-edge approach to combat solid tumors through the innovation of Selected Tumor-Infiltrating Lymphocyte (TIL) therapy. Their next-generation Selected TIL technology is engineered to selectively expand the most effective tumor-reactive T cells, positioning it...

Continue Reading
Arc and Curtin Maritime Forge Alliance for Electric Tugboats

Updated Category News Views 194

Arc Teams Up with Curtin Maritime for Hybrid Tugboats In a significant move towards the future of maritime operations, Arc has announced a substantial contract with Curtin Maritime, highlighting a $160 million deal aimed at producing eight hybrid-electric tugboats. This development represents a pivotal step in the electrification of commercial vessels, promising to...

Continue Reading
MP Materials Surges: Key Factors Behind the 531% Growth

Updated Category News Views 237

MP Materials: A Stellar Performance MP Materials Corp (NYSE: MP) has recently seen its stock skyrocket by an astonishing 531%, particularly from its notable four-year low. This surge, characterized by a robust upward trend over the past months, has captured the attention of investors and industry watchers alike. Two pivotal factors—partnerships with the Pentagon and...

Continue Reading
FP Movement Expands to Savannah: Opening Marks New Era

Updated Category News Views 16

FP Movement Steps into Savannah with New Boutique Alright, folks, there’s something brewing down in the historic streets of Savannah, Georgia. FP Movement, Free People's dynamic activewear line, is unveiling its newest outpost at 217 W Broughton St. on May 22, 2026. This isn't just another storefront—it's a strategic play to capture an uptick in lifestyle-oriented...

Continue Reading